Participants
NEUROBLASTOMA
Between September 2017 and February 2022, 49 patients were enrolled (A1 Baseline patient characteristics§ Two patients had crizotinib alone and also with chemotherapy.*Ceritinib, alectinib or ensartinibAll common neuroblastoma 